AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionJacobi Capital Management LLC
Latest Disclosed Ownership32,675 shares
Latest Disclosed Value $ 7,106,562
Jacobi Capital Management LLC reports 0.60% decrease in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Jacobi Capital Management LLC filed a 13F-HR form disclosing ownership of 32,675 shares of AbbVie Inc. (BG:4AB) valued at $7,106,562 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 32,873 shares of AbbVie Inc.. This represents a change in shares of -0.60% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 32,675 -198 -0.60 7,107 -5.39 0.3970
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 32,873 -672 -2.00 7,511 -3.28 0.4353
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 33,545 -122 -0.36 7,767 24.28 0.4728
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 33,667 496 1.50 6,249 -10.07 0.4148
2025-05-27 2025-03-31 13F ABBVIE COM 00287Y109 33,171 202 0.61 6,950 18.62 0.5126
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 32,969 -270 -0.81 5,859 -10.76 0.4375
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 33,239 675 2.07 6,564 17.53 0.4962
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 32,564 134 0.41 5,585 -5.42 0.4849
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 32,430 669 2.11 5,906 20.00 0.5458
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 31,761 464 1.48 4,922 5.49 0.5048
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 31,297 -71 -0.23 4,665 10.39 0.5273
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 31,368 -1,344 -4.11 4,226 -18.93 0.4727
2023-05-05 2023-03-31 13F ABBVIE COM 00287Y109 32,712 301 0.93 5,213 -0.48 0.6187
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 32,411 -348 -1.06 5,238 19.15 0.6550
2022-11-09 2022-09-30 13F ABBVIE COM 00287Y109 32,759 -322 -0.97 4,396 -13.24 0.6018
2022-08-05 2022-06-30 13F ABBVIE COM 00287Y109 33,081 -49 -0.15 5,067 -5.64 0.6741
2022-05-06 2022-03-31 13F ABBVIE COM 00287Y109 33,130 -459 -1.37 5,370 18.07 0.6416
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 33,589 1,503 4.68 4,548 31.41 0.5421
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 32,086 2,301 7.73 3,461 3.16 0.4401
2021-08-12 2021-06-30 13F ABBVIE COM 00287Y109 29,785 1,189 4.16 3,355 8.44 0.4434
2021-05-11 2021-03-31 13F ABBVIE COM 00287Y109 28,596 510 1.82 3,094 2.08 0.4567
2021-02-08 2020-12-31 13F ABBVIE COM 00287Y109 28,086 -100 -0.35 3,031 24.94 0.4785
2020-10-30 2020-09-30 13F ABBVIE COM 00287Y109 28,186 -1,972 -6.54 2,426 -17.87 0.4256
2020-08-04 2020-06-30 13F/A-1 ABBVIE COM 00287Y109 30,158 3,476 13.03 2,954 41.20 0.5523
2020-07-27 2020-06-30 13F ABBVIE COM 00287Y109 30,158 3,476 2,954 552,271.3421
2020-04-24 2020-03-31 13F ABBVIE COM 00287Y109 26,682 -1,258 -4.50 2,092 -13.23 0.4496
2020-02-03 2019-12-31 13F ABBVIE COM 00287Y109 27,940 1,020 3.79 2,411 17.50 0.4398
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 26,920 1,027 3.97 2,052 10.09 0.4060
2019-08-07 2019-06-30 13F ABBVIE COM 00287Y109 25,893 15,918 159.58 1,864 131.84 0.3787
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 9,975 1,464 17.20 804 2.42 0.2053
2019-02-11 2018-12-31 13F ABBVIE COM 00287Y109 8,511 2,171 34.24 785 30.83 0.2146
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 6,340 1,061 20.10 600 22.70 0.1604
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 5,279 3,215 155.77 489 158.73 0.1413
2018-05-03 2018-03-31 13F ABBVIE COM 00287Y109 2,064 959 86.79 189 71.82 0.0567
2018-02-05 2017-12-31 13F ABBVIE COM 00287Y109 1,105 -397 -26.43 110 -19.12 0.0356
2017-11-02 2017-09-30 13F ABBVIE COM 00287Y109 1,502 194 14.83 136 44.68 0.0461
2017-08-10 2017-06-30 13F ABBVIE COM 00287Y109 1,308 -70 -5.08 94 4.44 0.0364
2017-05-26 2017-03-31 13F ABBVIE COM 00287Y109 1,378 -113 -7.58 90 -1.10 0.0461
2017-02-08 2016-12-31 13F ABBVIE COM 00287Y109 1,491 -687 -31.54 91 -33.58 0.0555
2016-11-14 2016-09-30 13F ABBVIE COM 00287Y109 2,178 0 0.00 137 -0.72 0.0648
2016-11-14 2016-06-30 13F ABBVIE COM 00287Y109 2,178 2,178 138 0.0689
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.